Drug | Susceptible (%Â N) | Borderline susceptible (%Â N) | Resistant (%Â N) |
---|---|---|---|
[MIC range] | [MIC range] | [MIC range] | |
Kanamycin | 11 (50) | 10 (45) | 1 (5) |
[≤0.6-1.2 μg/ml] | [2.5-5.0 μg/ml] | [>40.0 μg/ml] | |
Amikacin | 15 (68) | 6 (27) | 1 (5) |
[≤0.12-0.25 μg/ml] | [≤0.5-1.0 μg/ml] | [16 μg/ml] | |
Ofloxacina | 12 (55) | 10 (45) | 0 |
[≤0.25-0.5 μg/ml] | [1.0-2.0 μg/ml] | N/A | |
Moxifloxacin | 11 (50) | 10 (45) | 1 (5) |
[≤0.6 μg/ml] | [≤0.12-0.25 μg/ml] | [0.5 μg/ml] | |
Ethionamide | 11 (50) | 8 (36) | 3 (14) |
[0.5-1.2Â ÎĽg/ml] | [2.5-5.0Â ÎĽg/ml] | [10.0-40.0Â ÎĽg/ml] | |
Cycloserine | 17 (77) | 5 (23) | 0 |
[1.2-8.0Â ÎĽg/ml] | [16.0-32.0Â ÎĽg/ml] | N/A | |
PAS | 15 (68) | 2 (9) | 5 (23) |
[≤0.5 μg/ml] | [1.0 μg/ml] | [8.0- >64.0 μg/ml] | |
Rifabutin | 9 (41) | 0 | 13 (59) |
[≤0.12 μg/ml] | N/A | [1.0- >16.0 μg/ml] |